L-NNA-sensitive regional cerebral blood flow augmentation during hypercapnia in type III NOS mutant mice

Am J Physiol. 1996 Oct;271(4 Pt 2):H1717-9. doi: 10.1152/ajpheart.1996.271.4.H1717.

Abstract

The effect of NG-nitro-L-arginine (L-NNA) on regional cerebral blood flow (rCBF) response to hypercapnia (5% CO2 inhalation) was studied in urethan-anesthetized wild-type (SV-129) and type III nitric oxide (NO) synthase (NOS)-deficient mice, using laser-Doppler flowmetry and the closed cranial window technique. Resting rCBF during normocapnia decreased by approximately 25% after L-NNA superfusion in wild-type mice only (n = 18), suggesting a role for type III NOS in baseline blood flow. Hypercapnia augmented rCBF approximately 50% in both wild-type and type III NOS mutant mice. L-NNA superfusion (1 mM) inhibited this increase by approximately 60% in both strains. Hence, synthesis of NO by the constitutively expressed type I NOS contributes to blood flow augmentation during hypercapnia.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Topical
  • Animals
  • Cerebrovascular Circulation / drug effects*
  • Enzyme Inhibitors / pharmacology*
  • Hypercapnia / genetics*
  • Hypercapnia / physiopathology*
  • Mice
  • Mice, Knockout / genetics*
  • Nitric Oxide Synthase / genetics*
  • Nitroarginine / pharmacology*
  • Vascular Resistance / drug effects

Substances

  • Enzyme Inhibitors
  • Nitroarginine
  • Nitric Oxide Synthase